Researchers@EVMS
Toggle navigation
Browse
Home
People
Departments
Research Areas
Capability Map
Publications
Events
Clinical Trials
Student Opportunities
FAQ
FUTURE ONCOLOGY
Journal
Overview
Identity
View All
Overview
publication venue for
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study
. 20:563-578.
2023
Identity
International Standard Serial Number (ISSN)
1479-6694
Electronic International Standard Serial Number (EISSN)
1744-8301
